Verastem (VSTM)

[stockguard]

Don`t forget currently $VSTM has these ongoing trials and more could be added per the conference call as Forrester stated there is still a lot of interest coming in for Defactinib combination usage:

May 2019
ClinicalTrials.gov Identifier: NCT02758587
Pancreatic Neoplasms / Drug: Defactinib

September 2019
ClinicalTrials.gov Identifier: NCT02004028
Malignant Pleural Mesothelioma / Drug: Defactinib VS-6063

July 31, 2020
ClinicalTrials.gov Identifier: NCT02546531
Advanced Cancer / Defactinib Combined With Pembrolizumab and Gemcitabine

Start April 2019 (Feb 2023)
ClinicalTrials.gov Identifier: NCT03727880
Pancreatic Ductal Adenocarcinoma / Drug: Defactinib

June 30, 2022
ClinicalTrials.gov Identifier: NCT02465060
Glioma / Drug: Defactinib

September 2023
ClinicalTrials.gov Identifier: NCT03287271
Carboplatin-resistant Ovarian Cancer / Defactinib (VS-6063) +Carboplatin/Paclitaxel